▶ 調査レポート

世界の治療用放射性医薬品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Therapeutic Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の治療用放射性医薬品市場 2021:企業別、地域別、種類・用途別 / Global Therapeutic Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X17402資料のイメージです。• レポートコード:GIR-105X17402
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、治療用放射性医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。治療用放射性医薬品の種類別市場規模(ラジウム-223、ルテチウム-177、ヨウ素-131、その他)、用途別市場規模(甲状腺、骨転移、リンパ腫、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・治療用放射性医薬品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Bayer、Novartis、China Isotope & Radiation、Dongcheng、Q BioMed、Curium Pharmaceuticals、Jubilant DraxImage、Lantheus、Spectrum Pharmaceuticals、Progenics Pharmaceuticals、International Isotopes
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ラジウム-223、ルテチウム-177、ヨウ素-131、その他
・用途別分析2016年-2026年:甲状腺、骨転移、リンパ腫、その他
・治療用放射性医薬品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・治療用放射性医薬品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・治療用放射性医薬品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・治療用放射性医薬品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・治療用放射性医薬品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Therapeutic Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Therapeutic Radiopharmaceuticals size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Therapeutic Radiopharmaceuticals market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Therapeutic Radiopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other

Market segment by Application can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other

The key market players for global Therapeutic Radiopharmaceuticals market are listed below:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Therapeutic Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Therapeutic Radiopharmaceuticals Sales in Value (2016-2026))
1.4.2 Global Therapeutic Radiopharmaceuticals Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)
1.5 Global Therapeutic Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Therapeutic Radiopharmaceuticals Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Radiopharmaceuticals Market Drivers
1.6.2 Therapeutic Radiopharmaceuticals Market Restraints
1.6.3 Therapeutic Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Therapeutic Radiopharmaceuticals Product and Services
2.1.4 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Therapeutic Radiopharmaceuticals Product and Services
2.2.4 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
2.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Dongcheng
2.4.1 Dongcheng Details
2.4.2 Dongcheng Major Business
2.4.3 Dongcheng Therapeutic Radiopharmaceuticals Product and Services
2.4.4 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Q BioMed
2.5.1 Q BioMed Details
2.5.2 Q BioMed Major Business
2.5.3 Q BioMed Therapeutic Radiopharmaceuticals Product and Services
2.5.4 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Curium Pharmaceuticals
2.6.1 Curium Pharmaceuticals Details
2.6.2 Curium Pharmaceuticals Major Business
2.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Jubilant DraxImage
2.7.1 Jubilant DraxImage Details
2.7.2 Jubilant DraxImage Major Business
2.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Product and Services
2.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Radiopharmaceuticals Product and Services
2.8.4 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Spectrum Pharmaceuticals
2.9.1 Spectrum Pharmaceuticals Details
2.9.2 Spectrum Pharmaceuticals Major Business
2.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Radiopharmaceuticals Product and Services
2.11.4 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Therapeutic Radiopharmaceuticals Sales by Manufacturer
3.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Radiopharmaceuticals Manufacturer Market Share
3.4.2 Top 6 Therapeutic Radiopharmaceuticals Manufacturer Market Share
3.5 Global Therapeutic Radiopharmaceuticals Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Radiopharmaceuticals Market Size by Region
4.1.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2016-2026)
4.2 North America Therapeutic Radiopharmaceuticals Revenue (2016-2026)
4.3 Europe Therapeutic Radiopharmaceuticals Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2016-2026)
4.5 South America Therapeutic Radiopharmaceuticals Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2016-2026)
5.3 Global Therapeutic Radiopharmaceuticals Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2016-2026)
6.3 Global Therapeutic Radiopharmaceuticals Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Radiopharmaceuticals Sales by Type (2016-2026)
7.2 North America Therapeutic Radiopharmaceuticals Sales by Application (2016-2026)
7.3 North America Therapeutic Radiopharmaceuticals Market Size by Country
7.3.1 North America Therapeutic Radiopharmaceuticals Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Radiopharmaceuticals Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Radiopharmaceuticals Sales by Type (2016-2026)
8.2 Europe Therapeutic Radiopharmaceuticals Sales by Application (2016-2026)
8.3 Europe Therapeutic Radiopharmaceuticals Market Size by Country
8.3.1 Europe Therapeutic Radiopharmaceuticals Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Therapeutic Radiopharmaceuticals Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Radiopharmaceuticals Sales by Type (2016-2026)
10.2 South America Therapeutic Radiopharmaceuticals Sales by Application (2016-2026)
10.3 South America Therapeutic Radiopharmaceuticals Market Size by Country
10.3.1 South America Therapeutic Radiopharmaceuticals Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Radiopharmaceuticals Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Therapeutic Radiopharmaceuticals Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Radiopharmaceuticals Typical Distributors
12.3 Therapeutic Radiopharmaceuticals Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Therapeutic Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Therapeutic Radiopharmaceuticals Product and Services
Table 6. Bayer Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Therapeutic Radiopharmaceuticals Product and Services
Table 10. Novartis Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 12. China Isotope & Radiation Major Business
Table 13. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
Table 14. China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 16. Dongcheng Major Business
Table 17. Dongcheng Therapeutic Radiopharmaceuticals Product and Services
Table 18. Dongcheng Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 20. Q BioMed Major Business
Table 21. Q BioMed Therapeutic Radiopharmaceuticals Product and Services
Table 22. Q BioMed Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharmaceuticals Major Business
Table 25. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 26. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 28. Jubilant DraxImage Major Business
Table 29. Jubilant DraxImage Therapeutic Radiopharmaceuticals Product and Services
Table 30. Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lantheus Basic Information, Manufacturing Base and Competitors
Table 32. Lantheus Major Business
Table 33. Lantheus Therapeutic Radiopharmaceuticals Product and Services
Table 34. Lantheus Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Spectrum Pharmaceuticals Major Business
Table 37. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 38. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Progenics Pharmaceuticals Major Business
Table 41. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 42. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 44. International Isotopes Major Business
Table 45. International Isotopes Therapeutic Radiopharmaceuticals Product and Services
Table 46. International Isotopes Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Therapeutic Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Therapeutic Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Therapeutic Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Therapeutic Radiopharmaceuticals Production Site of Key Manufacturer
Table 52. Global Therapeutic Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)
Table 53. Global Therapeutic Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)
Table 54. Global Therapeutic Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Therapeutic Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 57. Global Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 58. Global Therapeutic Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Therapeutic Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Therapeutic Radiopharmaceuticals Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Therapeutic Radiopharmaceuticals Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 63. Global Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 64. Global Therapeutic Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Therapeutic Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Therapeutic Radiopharmaceuticals Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Therapeutic Radiopharmaceuticals Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Therapeutic Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 69. North America Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 70. North America Therapeutic Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Therapeutic Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 73. North America Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 74. North America Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 75. North America Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 76. Europe Therapeutic Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 78. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 82. Europe Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 92. South America Therapeutic Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 93. South America Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 94. South America Therapeutic Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Therapeutic Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 97. South America Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 98. South America Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 99. South America Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Therapeutic Radiopharmaceuticals Typical Distributors
Table 111. Therapeutic Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Therapeutic Radiopharmaceuticals Picture
Figure 2. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 3. Radium-223
Figure 4. Lutetium-177
Figure 5. Iodine-131
Figure 6. Other
Figure 7. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Therapeutic Radiopharmaceuticals Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Therapeutic Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Therapeutic Radiopharmaceuticals Sales (2016-2026) & (K Units)
Figure 34. Global Therapeutic Radiopharmaceuticals Production Capacity (2016-2026) & (K Units)
Figure 35. Global Therapeutic Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Therapeutic Radiopharmaceuticals Market Drivers
Figure 37. Therapeutic Radiopharmaceuticals Market Restraints
Figure 38. Therapeutic Radiopharmaceuticals Market Trends
Figure 39. Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturer in 2020
Figure 40. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020
Figure 41. Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Therapeutic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Therapeutic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 45. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 46. North America Therapeutic Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 47. Europe Therapeutic Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 49. South America Therapeutic Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 51. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 52. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2016-2026)
Figure 53. Global Therapeutic Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 55. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2016-2026)
Figure 56. Global Therapeutic Radiopharmaceuticals Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 58. North America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 59. North America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 60. North America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 61. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 62. Europe Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 63. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 64. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 69. South America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 70. South America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 71. South America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 72. South America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source